EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Immunotherapy with B28, an antibody to Aβ oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in mice

Ting Yang, Yi Ran Xu, Shaomin Li, Jean-Pierre Bellier, Youqi Tao, Anna E Francis, Andrew M Stern, Shanxue Jin, Beth L Ostaszewski, Trebor L Lawton, Laurent Pradier, David Reczek und 3 weitere

Cell Reports · 2026-07 · 45 (7) · 117599

DOI: 10.1016/j.celrep.2026.117599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-07. Verfasst von Ting Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA…. Hauptthemen laut MEDLINE: Plaque, Amyloid, Amyloid beta-Peptides, Immunotherapy, Amyloid beta-Protein Precursor. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, Foundation for the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy against amyloid β-protein (Aβ) for Alzheimer's disease (AD) has been widely approved. Breakthrough disease-modifying treatments such as lecanemab and donanemab are often followed by drugs with improved efficacy. By immunizing Trianni mice with aggregated synthetic Aβ, we obtained B28, a fully human antibody specifically selected for its neutralization of tau neuritic dystrophy induced by AD brain-derived oligomers. In a blinded trial in mutant human APPNL-G-F knock-in mice, weekly infusions of B28 for four months markedly reduced both amyloid plaques and Aβ oligomers, attenuated plaque-associated astrocytosis and microgliosis, preserved neurons, and lessened memory decline. Biochemical and histological analyses showed that B28 engaged both plaque-bound and diffusible Aβ, forming immune complexes and depleting free Aβ. In in vitro immunoassays, B28 had significantly higher affinity and captured more Aβ from AD brain extracts than did lecanemab. B28 is a potent, aggregate-preferring Aβ antibody that clears plaques and decreases gliosis, supporting its clinical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AmyloidAmyloid beta-PeptidesImmunotherapyAmyloid beta-Protein PrecursorAlzheimer DiseaseGliosisMemory DisordersMicrogliaAnimalsHumansMiceMice, TransgenicGene Knock-In TechniquesBrainDisease Models, Animal

Stichwörter der Autor:innen

ADAlzheimer’s diseaseAβCP: neuroscienceamyloid β-proteinimmunotherapymouse model

Substanzen

Amyloid beta-PeptidesAmyloid beta-Protein Precursor

Autor:innen und Institutionen

  • Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA. Electronic address: tyang@bwh.harvard.edu.
  • Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA.
  • Abyssinia Biologics, Inc, 855 Boylston Street, #1000, Boston, MA 02116, USA.
  • Sanofi Neurodegenerative Research, Chilly Mazarin, France.
  • Sanofi US Large Molecule Research, 350 Water St, Cambridge, MA 02141, USA.
  • Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115, USA. Electronic address: dselkoe@bwh.harvard.edu.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • Foundation for the National Institutes of Health
  • National Institutes of Health

Zitieren

APA

Yang, T., Xu, Y. R., Li, S., Bellier, J. P., Tao, Y., Francis, A. E., Stern, A. M., Jin, S., Ostaszewski, B. L., Lawton, T. L., Pradier, L., Reczek, D., Lemere, C. A., Walsh, D. M., & Selkoe, D. J. (2026). Immunotherapy with B28, an antibody to Aβ oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in mice. Cell Reports, 45(7), 117599. https://doi.org/10.1016/j.celrep.2026.117599

Vancouver

Yang T, Xu YR, Li S, Bellier JP, Tao Y, Francis AE, et al. Immunotherapy with B28, an antibody to Aβ oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in mice. Cell Reports. 2026;45(7):117599. doi:10.1016/j.celrep.2026.117599

BibTeX
@article{Yang2026,
  author = {Yang, Ting and Xu, Yi Ran and Li, Shaomin and Bellier, Jean-Pierre and Tao, Youqi and Francis, Anna E and Stern, Andrew M and Jin, Shanxue and Ostaszewski, Beth L and Lawton, Trebor L and Pradier, Laurent and Reczek, David and Lemere, Cynthia A and Walsh, Dominic M and Selkoe, Dennis J},
  title = {Immunotherapy with B28, an antibody to Aβ oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in mice},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {117599},
  doi = {10.1016/j.celrep.2026.117599}
}
Kostenlos starten →